Results 1 to 10 of about 921,945 (165)

Guillain–Barre syndrome after antithymocyte globulin administration in a kidney transplant recipient: A case report and literature review

open access: yesClinical Case Reports, 2023
Key Clinical Message This report describes a rare case of developing Guillain–Barre syndrome (GBS) following receiving rabbit antithymocyte globulin (ATG) after kidney transplantation to prevent acute allograft rejection in a 34‐year‐old man. The patient
Farnaz Tavakoli   +3 more
doaj   +2 more sources

Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2019
Background/Aims Anti-thymocyte globulin (ATG) treatment for acute T-cell mediated rejection (TCMR) can increase the risk of cytomegalovirus (CMV) infection.
Eun Jeong Ko   +3 more
doaj   +1 more source

The intragraft vascularized bone marrow induces secondary donor-specific mystacial pad allograft tolerance

open access: yesFrontiers in Immunology, 2022
IntroductionVascularized bone marrow (VBM) is essential in tolerance induction through chimerism. We hypothesized that the inclusion of VBM contributes to the induction of mystacial pad allotransplantation tolerance.MethodIn this study, 19 VBM, nine ...
Cheng-Hung Lin   +6 more
doaj   +1 more source

Bioimaging of alloantigen-stimulated regulatory T cells in rat vascularized composite allotransplantation. [PDF]

open access: yesPLoS ONE, 2018
BACKGROUND:Tipping the balance toward regulatory T cells (Tregs) through adoptive cell therapy has shown promise to induce transplantation tolerance. Although such strategy has been explored in many mice organ transplantation studies, less knowledge was ...
Hui-Yun Cheng   +9 more
doaj   +1 more source

Immunomodulation with Intrathymic Grafts or Anti-Lymphocyte Serum Promotes Long-Term Intraspinal Allograft Survival

open access: yesCell Transplantation, 1996
In this study, we sought to test whether introduction of fetal cells into the adult rat thymus would promote immunotolerance to subsequent donor-type allografts in the injured spinal cord.
Daniel P. Theele, Paul J. Reier Ph.D.
doaj   +1 more source

Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case report

open access: yesJournal of Medical Case Reports, 2007
Background The use of antilymphocyte agents has improved patient and graft survival in hematopoietic stem cell and solid organ transplantation but has been associated with the development of short-term toxicities as well as long-term complications.
Al-Anazi Khalid A   +5 more
doaj   +1 more source

Heart Allograft Tolerance Induced and Maintained by Vascularized Hind-Limb Transplant in Rats

open access: yesClinical and Developmental Immunology, 2013
Organ/tissue transplantation has become an effective therapy for end-stage diseases. However, immunosuppression after transplantation may cause severe side effects. Donor-specific transplant tolerance was proposed to solve this problem. In this study, we
Quan Liu   +5 more
doaj   +1 more source

Successful Single Donor Islet Allotransplantation in the Streptozotocin Diabetes Rat Model

open access: yesCell Transplantation, 2002
The objective of this study was to define pretransplant islet culture conditions for optimum tissue engraftment in the rat islet allotransplantation model. Lewis rat islets were cultured in TCM 199/5% fetal calf serum for 1 day at 37°C, followed by 1 day
Henning Jahr   +3 more
doaj   +1 more source

Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

open access: yesКлиническая онкогематология, 2019
Background & Aims. Paroxysmal nocturnal hemoglobinuria (PNH) is a disease caused by an acquired clonal disorder of hematopoietic stem cells with clone cell membrane hypersensitivity to the complement.
Elena Romanovna Shilova   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy